Delivery Order SPE2DB24D9222-SPE2DB25FAZEX
Award Date
2/25/25
Potential Completion Date
3/18/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,010.76 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,004.53, is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring pharmaceutical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $4,006.04 and is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. The contract has a period of performance through May 9, 2024 and does not have a set-aside designation. This delivery order contract is part of a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,006.04 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of OZURDEX 0.7 MG IMPLANTS. This order was placed under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items in support of military health facilities worldwide. The contract has a period of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product, with a completion date of February 22, 2024 and a potential value of $2,003.02. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds a separate indefinite delivery contract with DLA,...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, with a potential value of $2,003.02 and a completion date of February 22, 2024. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with the DLA, contract number 4600082013 under the SPE2DB program, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of OZURDEX 0.7 MG IMPLANTS. The total potential value of the contract is $3,004.53, with a period of performance through April 10, 2024. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Vehicle (IDV) contract, SPE2DB, with the DLA valued at up to $4,999,999 through the end of 2025. This IDV enables the DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, with a ceiling value of $3,004.53 and a period of performance through July 17, 2024. The contract is not set aside and is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, with a potential value of $3,004.53 and a completion date of March 7, 2024. This delivery order is likely part of DMS Pharmaceutical Group's broader indefinite delivery contract with DLA, contract 4600082013 under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,003.02 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product, with a completion date of March 4, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued up to $4,999,999, with the Defense Logistics Agency for the supply of a broad...